Home
CMRX
CMRX News

Latest Chimerix Inc. (CMRX) News on July 27, 2024

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

21 days ago

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference

Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript

GuruFocus.com

3 months ago

Chimerix Inc (CMRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Chimerix Inc Earnings Call

Associated Press Finance

3 months ago

Chimerix: Q1 Earnings Snapshot

Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update

GlobeNewswire

3 months ago

Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024

GlobeNewswire

3 months ago

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

We Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully

Simply Wall St.

3 months ago

We Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully

Chimerix Appoints Marc D. Kozin to Board of Directors

GlobeNewswire

4 months ago

Chimerix Appoints Marc D. Kozin to Board of Directors

Chimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

5 months ago

Chimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Chimerix Inc Earnings Call

Chimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Results

GuruFocus.com

5 months ago

Chimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Results

Associated Press Finance

5 months ago

Chimerix: Q4 Earnings Snapshot

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update

GlobeNewswire

5 months ago

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update

Chimerix to Present at TD Cowen 44th Annual Health Care Conference

GlobeNewswire

5 months ago

Chimerix to Present at TD Cowen 44th Annual Health Care Conference

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024

GlobeNewswire

5 months ago

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024

Chimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with institutions

Simply Wall St.

5 months ago

Chimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with institutions

Clearfield (CLFD) Declined in 2023

Insider Monkey

6 months ago

Clearfield (CLFD) Declined in 2023

Why First Savings Financial (FSFG) is a Great Dividend Stock Right Now

Zacks

6 months ago

Why First Savings Financial (FSFG) is a Great Dividend Stock Right Now

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

PR Newswire

6 months ago

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

Arbe Celebrates Milestone Achievements as Sensrad Announces Major Customer Orders for Revolutionary Radar Technology

GlobeNewswire

6 months ago

Arbe Celebrates Milestone Achievements as Sensrad Announces Major Customer Orders for Revolutionary Radar Technology

Toro Corp. Announces the Sale of the M/T Wonder Sirius for $33.8 Million with an Expected Net Gain of $20.9 Million

GlobeNewswire

6 months ago

Toro Corp. Announces the Sale of the M/T Wonder Sirius for $33.8 Million with an Expected Net Gain of $20.9 Million

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

6 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

American Resources Corporation's ReElement Technologies Engages Law Firm Alexander & Partner for Formation of ReElement Ghana

ACCESSWIRE

6 months ago

American Resources Corporation's ReElement Technologies Engages Law Firm Alexander & Partner for Formation of ReElement Ghana

HYZON ACHIEVES 2023 VEHICLE DEPLOYMENT AND FUEL CELL DEVELOPMENT MILESTONES

PR Newswire

7 months ago

HYZON ACHIEVES 2023 VEHICLE DEPLOYMENT AND FUEL CELL DEVELOPMENT MILESTONES

With 37% ownership, Immuneering Corporation (NASDAQ:IMRX) has piqued the interest of institutional investors

Simply Wall St.

7 months ago

With 37% ownership, Immuneering Corporation (NASDAQ:IMRX) has piqued the interest of institutional investors

Risky Retail: 3 Stocks Investors Should Avoid in 2024

InvestorPlace

7 months ago

Risky Retail: 3 Stocks Investors Should Avoid in 2024

Chimerix Appoints Lisa Decker to Board of Directors

GlobeNewswire

7 months ago

Chimerix Appoints Lisa Decker to Board of Directors

Osisko Development Announces Management Updates

GlobeNewswire

7 months ago

Osisko Development Announces Management Updates

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

Business Wire

7 months ago

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

Heritage Announces Closing of Primary Public Offering of Shares of Common Stock and Concurrent Private Placement

PR Newswire

7 months ago

Heritage Announces Closing of Primary Public Offering of Shares of Common Stock and Concurrent Private Placement

Insider Sell: EVP and COO David Sweitzer Sells 23,559 Shares of Quest Resource Holding Corp (QRHC)

GuruFocus.com

7 months ago

Insider Sell: EVP and COO David Sweitzer Sells 23,559 Shares of Quest Resource Holding Corp (QRHC)

3 Penny Stocks That Are About to Get Absolutely Crushed

InvestorPlace

7 months ago

3 Penny Stocks That Are About to Get Absolutely Crushed

Positive Signs As Multiple Insiders Buy Chimerix Stock

Simply Wall St.

7 months ago

Positive Signs As Multiple Insiders Buy Chimerix Stock

Ames National (NASDAQ:ATLO) Will Pay A Dividend Of $0.27

Simply Wall St.

7 months ago

Ames National (NASDAQ:ATLO) Will Pay A Dividend Of $0.27

PR Newswire

7 months ago

BARINGTON CAPITAL GROUP CALLS FOR TRIMAS CORPORATION TO ADDRESS ITS LONG-TERM SHARE PRICE UNDERPERFORMANCE

Why Is Amicus Therapeutics (FOLD) Up 15% Since Last Earnings Report?

Zacks

8 months ago

Why Is Amicus Therapeutics (FOLD) Up 15% Since Last Earnings Report?

Findell Capital Management LLC Issues Statement to the Stockholders of Oportun Financial Corporation

PR Newswire

8 months ago

Findell Capital Management LLC Issues Statement to the Stockholders of Oportun Financial Corporation

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer

GlobeNewswire

8 months ago

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

GlobeNewswire

8 months ago

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

GlobeNewswire

8 months ago

Quetta Acquisition Corporation Announces the Separate Trading of its Common Stock and Rights, Commencing on November 30, 2023

Eastern (NASDAQ:EML) Will Want To Turn Around Its Return Trends

Simply Wall St.

8 months ago

Eastern (NASDAQ:EML) Will Want To Turn Around Its Return Trends

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PR Newswire

8 months ago

VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES QUARTERLY CASH DIVIDEND

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer

GlobeNewswire

8 months ago

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer

Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update

PR Newswire

8 months ago

Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update

GuruFocus.com

8 months ago

Stratus Properties Inc (STRS) Faces Net Loss in Q3 2023 Despite Strong Cash Position and Share ...

Associated Press Finance

8 months ago

Stratus Properties: Q3 Earnings Snapshot

Business Wire

8 months ago

Stratus Properties Inc. Reports Third-Quarter 2023 Results

Unifi, Inc. (NYSE:UFI) is definitely on the radar of institutional investors who own 50% of the company

Simply Wall St.

8 months ago

Unifi, Inc. (NYSE:UFI) is definitely on the radar of institutional investors who own 50% of the company

ClearPoint Neuro Reports Third Quarter 2023 Results

GlobeNewswire

9 months ago

ClearPoint Neuro Reports Third Quarter 2023 Results

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Granite Point Mortgage Trust Inc Earnings Call

BlackSky Reports Third Quarter 2023 Results

Business Wire

9 months ago

BlackSky Reports Third Quarter 2023 Results

Associated Press Finance

9 months ago

Granite Point Mortgage Trust: Q3 Earnings Snapshot

GuruFocus.com

9 months ago

Granite Point Mortgage Trust Inc. (GPMT) Reports Q3 2023 Results Amid Real Estate Market Headwinds

Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission

PR Newswire

9 months ago

Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission

Share on Social Networks: